Search for Clinical Trial Results

Sponsored By

Acinic Cell Carcinoma - 45 Studies Found

Status Study
Suspended Study Name: Selinexor, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Pancreatic Cancer
Condition:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Date: 2014-06-23
    Interventions:
    • Drug: gemcitabine hydrochloride

Completed Study Name: Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
Condition:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Date: 2013-01-15
    Interventions:
    • Drug: porfimer sodium Given IV
Completed Study Name: Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer
Condition:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Date: 2006-12-27
    Interventions:
    • Drug: bortezomib Given IV
Completed Study Name: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
Condition:
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Ductal Adenocarcino
    Date: 2012-08-03
    Interventions:
    • Drug: Akt Inhibitor MK2206 Giv
Active, not recruiting Study Name: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Condition:
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Ductal Adenocarcino
    Date: 2011-01-18
    Interventions:
    • Drug: Carboplatin Given IV
Active, not recruiting Study Name: Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Condition:
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Ductal Adenocarcino
    Date: 2008-04-29
    Interventions:
    • Biological: Falimarev Given in
Completed Study Name: Stereotactic Radiosurgery and Metformin Hydrochloride in Treating Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer
Condition:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Date: 2014-05-30
    Interventions:
    • Drug: metformin hydrochloride

Active, not recruiting Study Name: CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
Condition:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Date: 2013-04-16
    Interventions:
    • Drug: 6,8-bis(benzylthio)octanoic acid

Active, not recruiting Study Name: Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery
Condition:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Date: 2012-11-29
    Interventions:
    • Drug: gemcitabine hydrochloride

Completed Study Name: Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer
Condition:
  • Acinar Cell Adenocarcinoma of the Pancreas
  • Duct Cell Adenocarci
    Date: 2012-08-14
    Interventions:
    • Drug: metformin hydrochloride

Next >>>